Long-term efmoroctocog alfa prophylaxis improves perceived pain, mental, and physical health in patients with hemophilia A: analysis of phase III trials using patient-reported outcomes.

Journal: Therapeutic advances in hematology

Publication Year: 

Authors & Co-authors:  Raheja Priyanka P Kragh Nana N Bystrická Linda L Eriksson Daniel D Aroui Khaoula K Mezghani Marwa M Barbier Sylvaine S Linari Silvia S

Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: analysis of phase III trials using patient-reported outcomes.

Journal: Therapeutic advances in hematology

Publication Year: 

Authors & Co-authors:  Astermark Jan J Hermans Cédric C Ezzalfani Monia M Sidhom Alaeddine A Barbier Sylvaine S Kragh Nana N Falk Aletta A Eriksson Daniel D